Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Mersana Therapeutics Inc. (MRSN)

18.53   -0.09 (-0.48%) 10-01 15:01
Open: 18.69 Pre. Close: 18.62
High: 18.83 Low: 17.96
Volume: 815,822 Market Cap: 1,268M
Mersana Therapeutics, Inc. engages in the development and manufacture of antibody drug conjugates to improve patient outcomes in oncology indications. The company is headquartered in Cambridge, Massachusetts and currently employs 86 full-time employees. The firm is focused on discovering and developing a pipeline of antibody drug conjugates (ADCs). The firm focuses on advancing a pipeline of targeted oncology therapeutics leveraging its Fleximer immunoconjugate technology. The Fleximer platform allows it to design ADCs with specific properties and manage the drug's chances of attacking cancers. Its product candidates include XMT-1522 and XMT-1536. The ADC therapies treat cancer patients by engineering a drug conjugate with various anti-cancer agents and controlling when, where and how those agents are released. Dolaflexin is its Fleximer antibody drug conjugation platform, which pairs the Fleximer polymer with its linker chemistries to create ADC therapies.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 19.478 - 19.588 19.588 - 19.708
Low: 17.814 - 17.931 17.931 - 18.058
Close: 18.395 - 18.602 18.602 - 18.828

Technical analysis

as of: 2020-10-01 2:36:59 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 26.12     One year: 31.12
Support: Support1: 15.44    Support2: 12.85
Resistance: Resistance1: 22.36    Resistance2: 26.64
Pivot: 20.77
Moving Average: MA(5): 18.77     MA(20): 19.94
MA(100): 19.25     MA(250): 11.08
MACD: MACD(12,26): -0.10     Signal(9): 0.25
Stochastic oscillator: %K(14,3): 16.28     %D(3): 24.04
RSI: RSI(14): 44.69
52-week: High: 26.64  Low: 1.32  Change(%): 992.3
Average Vol(K): 3-Month: 94126  10-Days: 172311

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
MRSN has closed above bottom band by 26.3%. Bollinger Bands are 59% wider than normal. The large width of the bands suggest high volatility as compared to MRSN's normal range. The bands have been in this wide range for 11 bars. This is a sign that the current trend might continue.

Headline News

Thu, 01 Oct 2020
Mersana Therapeutics Inc. (MRSN) is on the roll with an average volume of 946.92K in the recent 3 months - The InvestChronicle

Thu, 01 Oct 2020
Mersana Therapeutics, Inc. (NASDAQ:MRSN) 6.48% up over a week, Can The Stock Hit well above $19.91-? - Marketing Sentinel

Tue, 29 Sep 2020
Hedge Funds Keep Into Mersana Therapeutics, Inc. (MRSN) - Yahoo Finance

Sat, 26 Sep 2020
Zacks: Brokerages Expect Mersana Therapeutics Inc (NASDAQ:MRSN) Will Announce Quarterly Sales of $430,000.00 - MarketBeat

Mon, 21 Sep 2020
Why Mersana Therapeutics' (NASDAQ:MRSN) CEO Pay Matters - Yahoo Finance

Thu, 17 Sep 2020
Revisiting Mersana Therapeutics (MRSN) - Nasdaq

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 68
Shares Float (M) 46
% Held by Insiders 1.28
% Held by Institutions 64.26
Shares Short (K) 5,840
Shares Short P. Month (K) 4,830

Stock Financials

EPS -1.370
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 4.000
Profit Margin
Operating Margin -4183.34
Return on Assets (ttm) -19.7
Return on Equity (ttm) -36.5
Qtrly Rev. Growth 294.1
Gross Profit (p.s.) -0.189
Sales Per Share 0.025
EBITDA (p.s.) -1.019
Qtrly Earnings Growth
Operating Cash Flow (M) -66
Levered Free Cash Flow (M) -40

Stock Valuations

PE Ratio -13.47
PEG Ratio
Price to Book value 4.61
Price to Sales 747.36
Price to Cash Flow -19.13

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.